These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7287006)

  • 21. Polymorphism of BF, C2, and GLO in Japanese patients with insulin-dependent diabetes mellitus: confirmation of an increase of BF*FT.
    Tokunaga K; Omoto K; Juji T; Itoh T
    Hum Genet; 1982; 62(1):86-8. PubMed ID: 6924917
    [No Abstract]   [Full Text] [Related]  

  • 22. C2 reference typing report.
    Jahn I; Uring-Lambert B; Arnold D; Clemenceau S; Hauptmann G
    Complement Inflamm; 1990; 7(4-6):175-82. PubMed ID: 2088655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complement polymorphism in Greece.
    Triantaphyllidis CD; Ad'hiah A; Karkousis J; Papiha SS
    Ann Hum Biol; 1989; 16(5):443-8. PubMed ID: 2802524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous detection of allotypes in native and activated human C2 by isoelectric focusing and silver staining.
    Segurado OG; Arnaiz-Villena A
    J Immunol Methods; 1989 Feb; 117(1):9-15. PubMed ID: 2464040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequency in Spanish population of familial complement factor 2 type I deficits and associated HLA haplotypes.
    Antolín SC; Del Rey Cerros MJ; Sierra EM; Miñarro DO; Clemente J; Martínez LA; Peña PV; Panete MJ; Pérez PM; Paz-Artal E
    Hum Immunol; 2005 Oct; 66(10):1093-8. PubMed ID: 16386652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The HLA system in the Korean population.
    Kim SJ; Nisperos B; Mickelson E; Choi IH; Dahlberg S; Kim JD; Giblett ER; Hansen JA
    Hum Immunol; 1986 Nov; 17(3):259-72. PubMed ID: 3793531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of low C2 and C4 serum levels with the HLA-DW2 allele in healthy individuals.
    Nerl C; Grosse-Wilde H; Valet G
    J Exp Med; 1978 Sep; 148(3):704-13. PubMed ID: 702053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The location of C2, C4, and BF relative to HLA-B and HLA-D.
    Raum DD; Awdeh ZL; Glass D; Yunis E; Alper CA
    Immunogenetics; 1981 Mar; 12(5-6):473-83. PubMed ID: 7216322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular heterogeneity of second and fourth components of complement and their genes in systemic sclerosis and association of HLA alleles A1, B8 and DR3 with limited and DR5 with diffuse systemic sclerosis.
    Venneker GT; van den Hoogen FH; van Meegen M; de Kok-Nazaruk M; Hulsmans RF; Boerbooms AM; de Waal LP; Bos JD; Asghar SS
    Exp Clin Immunogenet; 1998; 15(2):90-9. PubMed ID: 9691203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C2 and factor B: structure and genetics.
    Bentley DR; Campbell RD
    Biochem Soc Symp; 1986; 51():7-18. PubMed ID: 3101701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different HLA antigen associations for the functionally active and inactive products of the complement C4F1 allele.
    O'Neill GJ; Miniter P; Pollack MS; Dupont B
    Hum Immunol; 1980 Jul; 1(1):23-30. PubMed ID: 7263310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic polymorphisms of properdin factor B(Bf), the second component (C2), and the fourth component (C4) of complement in leprosy patients and healthy controls from Thailand.
    Greiner J; Weber FJ; Mauff G; Baur M
    Immunobiology; 1980; 158(1-2):134-8. PubMed ID: 6907169
    [No Abstract]   [Full Text] [Related]  

  • 33. Polymorphism of the second component of complement (C2) in Graves' disease.
    Noel EP; Sampson L; Pepper BM; Farid NR
    Hum Hered; 1980; 30(4):245-7. PubMed ID: 6893039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA and C4 in subacute sclerosing panencephalitis.
    Harada F; Onisawa S; Suzuki K; Matsumoto H; Sasazuki T
    Tissue Antigens; 1987 Aug; 30(2):73-5. PubMed ID: 3672494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA-Cw alleles associated with HLA extended haplotypes and C2 deficiency.
    Clavijo OP; Delgado JC; Awdeh ZL; Fici D; Turbay D; Alper CA; Truedsson L; Yunis EJ
    Tissue Antigens; 1998 Sep; 52(3):282-5. PubMed ID: 9802610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allele polymorphism and haplotype diversity of HLA-A, -B and -DRB1 loci in sequence-based typing for Chinese Uyghur ethnic group.
    Shen CM; Zhu BF; Deng YJ; Ye SH; Yan JW; Yang G; Wang HD; Qin HX; Huang QZ; Zhang JJ
    PLoS One; 2010 Nov; 5(11):e13458. PubMed ID: 21079793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incomplete functional deficiencies of the fourth (C4) and second (C2) components of complement in a patient with linear frontoparietal scleroderma and his family. Deficiencies determined by a gene not linked to human leukocyte antigen system.
    Venneker GT; van Meegen M; de Kok-Nazaruk M; Hulsmans RF; de Waall LP; Bos JD; Asghar SS
    Exp Clin Immunogenet; 1996; 13(2):104-11. PubMed ID: 9063702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Linkage relationship of C2 deficiency, HLA and glyoxalase I loci.
    Mahowald ML; Dalmasso AP; Petzel RA; Yunis EJ
    Vox Sang; 1979; 37(6):321-8. PubMed ID: 161677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human histocompatibility leukocyte antigen (HLA) haplotype frequencies estimated from the data on HLA class I, II, and III antigens in 111 Japanese narcoleptics.
    Matsuki K; Juji T; Tokunaga K; Naohara T; Satake M; Honda Y
    J Clin Invest; 1985 Dec; 76(6):2078-83. PubMed ID: 3865934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA polymorphism of the C2 and factor B gene.
    Cross SJ; Thomson W
    Exp Clin Immunogenet; 1990; 7(1):53-63. PubMed ID: 1971758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.